Dr. Clive Glover leads Pall Biotech’s cell and gene therapy strategy.
Previously, he was responsible for driving product development efforts
around cell therapy at GE Healthcare and has also held positions in
marketing and product management at STEMCELL Technologies.
Clive holds a Ph.D. in Genetics from the University of British Columbia.